Evidence map›Paper›PMID 33899637›Full record

ReviewExpert opinion on investigational drugs2021

Dementia with Lewy bodies: emerging drug targets and therapeutics.

Evans D Pope, Laura Cordes, Jiong Shi, Zoltan Mari, Boris Decourt, Marwan Noel Sabbagh

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Expert opinion on investigational drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Drug Discovery and Development Targeting Dementia.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Evans D PopeLou Ruvo Center for Brain Health, Cleveland Clinic Nevada, Las Vegas, NV, USA.
Laura CordesLou Ruvo Center for Brain Health, Cleveland Clinic Nevada, Las Vegas, NV, USA.
Jiong ShiLou Ruvo Center for Brain Health, Cleveland Clinic Nevada, Las Vegas, NV, USA.
Zoltan MariLou Ruvo Center for Brain Health, Cleveland Clinic Nevada, Las Vegas, NV, USA.
Boris DecourtLou Ruvo Center for Brain Health, Cleveland Clinic Nevada, Las Vegas, NV, USA.
Marwan Noel SabbaghLou Ruvo Center for Brain Health, Cleveland Clinic Nevada, Las Vegas, NV, USA.
Cleveland Clinic · USLou Ruvo Brain Institute · US

Funding

Project 3: Biomarkers for DS Clinical TrialsU19AG068054 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COHEN, ANN D. · 2020 to 2025
$103.7M
Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) CNTN - ResubmissionP20GM109025 · NIGMS · CLEVELAND CLINIC FOUNDATION · PI JESSICA KIRKLAND CALDWELL · 2015 to 2026
$22.8M
MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI PatientsR01AG059008 · NIA · ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER · PI DECOURT, BORIS, SABBAGH, MARWAN NOEL · 2018 to 2023
$3.6M
NVEDARC Clinical CoreP20AG068053 · NIA · CLEVELAND CLINIC FOUNDATION · PI FOX, ROBERT J. · 2020 to 2022
$3.3M
NIA NIH HHS P20 AG068053NIA NIH HHS R01 AG059008NIA NIH HHS U19 AG068054NIGMS NIH HHS P20 GM109025
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug DevelopmentMolecular Targeted TherapyAlzheimer DiseaseAnimalsDrug RepositioningHumansLewy Body DiseaseParkinson DiseaseClinical trialsdementiadementia with Lewy bodiesdrug developmentdrug repurposingdrug targetsLewy body dementiaParkinson’s diseasesynucleinopathy

Identifiers

PMID33899637
PMCPMC9169612
OpenAlexW3159736734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.